Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRECCO-19: Colchicine in COVID-19
NCT04326790Phase 2Terminated
- Sponsor
- National and Kapodistrian University of Athens
- Start
- Apr 2020
- Primary completion
- Apr 2020
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of colchicine in coronavirus disease 2019 (COVID-19), sponsored by National and Kapodistrian University of Athens. Started Apr 2020; status: terminated.
02
Drugs
colchicine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04326790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04326790.